Peripheral Venous Pressure (PVP) Trial

Exclusion Criteria

• •Patients who do not already have a peripheral IV line inserted
• •Patients whose IV line cannot be transduced
• •Patients with current or past vein thrombosis in the arm used to measure the pressure or with history of recurrent (\>1) pulmonary embolism
• •Patients with active thrombophlebitis in the arm
• •Patients who have experienced a major cardiovascular event (myocardial infarction, stroke, etc.) ≤2 months prior to the admission date
• •Patients who have received an implanted cardiac resynchronization device (pacemaker or ICD) ≤3 months prior to admission date
• •Patients enrolled in other cardiovascular research studies.
• •Patients with a clinical condition that the investigator believes may not allow the patient to complete the study, at the discretion of the investigator. Examples of conditions that may apply include severe stenotic valvular disease, isolated right ventricle failure, precapillary pulmonary hypertension, hypertrophic obstructive cardiomyopathy, implanted left ventricular assist device, history of heart transplantation, clinical diagnosis of cardiogenic shock, any left-to-right shunt
• •Patients with congenital heart disease or mechanical right heart valve(s)
• •Planned heart surgery and/or coronary intervention during hospitalization
• •Patients expected to receive heart transplant within 6 months of admission
• •IV cannula smaller than 22G
• •Patients who are pregnant and/or lactating
• •Patients who are unable to provide informed consent
• •Patients who are intubated